So the pundits still try to claim the lack of evidence for the use of POCUS, bla, bla bla. Just wait till they get a load of this: POCUS in delirium? Master Andre Denault introduces us here to a completely new way of assessing a little known potential aetiology of acute delirium.
Here it is, certainly one of the most interesting and forward-thinking lectures of H&R2019:
So I’m really glad to see that recently, a lot of discussion has been taken place on the topic of right sided failure and venous congestion, which has huge clinical applications. Even more so, the fact that a lot of individual practitioners have taken this on and have been applying it clinically with physiological results is really amazing.
So a common question that has been popping up revolves around clinical thresholds of significance, and I thought it was worth clarifying that we need to stay away from a pure threshold approach, but rather try to embrace a holistic cardio pulmonary and whole body assessment.
So here’s my two cents:
Thank you, love to hear any comments!
Philippe
ps obviously, this type of discussion will be what H&R2020 will be chock full of!
So metabolic resuscitation is a topic that both Josh (@Pulmcrit) and I are really interested in. We were looking forward to the CITRUS-ALI study. The results, to me, are good. They continue to establish the fact that there are no real side effects, particularly renal, as this was a concern to some (despite the already large data sets – particularly in the Matsuda study), and in an even higher dose than the Marik study.
Of course since the study was not designed to show a mortality benefit, it wouldn’t be clean to tout their results from that angle, but it certainly should be hypothesis-generating (imagine the cheers from the pundits who would certainly have used it in reverse had the mortality been increased instead!!!). So for me, it changes nothing, because – if my institution hadn’t decreed (for no legitimate reason I can see) that I cannot use it in patients that I feel would benefit – I would still use it as an adjunct to septic shock management.
There are more studies around the corner, and hope they will come out before next may, so that Josh can give us an update for H&R2020 (#Hresus20)!
thinking critical care 